Li Xin Niu
Director of Finance/CFO at AIM VACCINE CO., LTD.
Profile
Li Xin Niu is currently the Chief Financial Officer at AIM Vaccine Co., Ltd.
She previously worked as the Vice President-Finance at China Nuokang Bio-Pharmaceutical, Inc. from 2006 to 2012.
Before that, she was the Chief Financial Officer & Director at Beijing Dingcheng Weiye Technology Co., Ltd.
in 2003, Chief Financial Officer at Singapore City One Group Telecom Ltd.
(China) in 2005, and Vice President at Liaoning Zhongping Accounting Co., Ltd.
in 2006.
Ms. Niu received her undergraduate degree from Shenyang Industrial University in 1993 and her MBA from W.P.
Carey School of Business in 2020.
Li Xin Niu active positions
Companies | Position | Start |
---|---|---|
AIM VACCINE CO., LTD. | Director of Finance/CFO | 2015-09-30 |
Former positions of Li Xin Niu
Companies | Position | End |
---|---|---|
China Nuokang Bio-Pharmaceutical, Inc.
China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | Director of Finance/CFO | 2010-12-14 |
Liaoning Zhongping Accounting Co., Ltd. | Corporate Officer/Principal | 2006-10-31 |
Singapore City One Group Telecom Ltd. (China) | Director of Finance/CFO | 2005-02-28 |
Beijing Dingcheng Weiye Technology Co., Ltd. | Director of Finance/CFO | 2003-11-30 |
Training of Li Xin Niu
Shenyang Industrial University | Undergraduate Degree |
W.P. Carey School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
AIM VACCINE CO., LTD. | Health Technology |
Private companies | 4 |
---|---|
China Nuokang Bio-Pharmaceutical, Inc.
China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | Health Technology |
Beijing Dingcheng Weiye Technology Co., Ltd. | |
Singapore City One Group Telecom Ltd. (China) | |
Liaoning Zhongping Accounting Co., Ltd. |
- Stock Market
- Insiders
- Li Xin Niu